Literature DB >> 9669700

The prion diseases.

S B Prusiner1.   

Abstract

The human prion diseases are fatal neurodegenerative maladies that may present as sporadic, genetic, or infectious illnesses. The sporadic form is called Creutzfeldt-Jakob disease (CJD) while the inherited disorders are called familial (f) CJD, Gerstmann-Straussler-Scheinker (GSS) disease and fatal familial insomnia (FFI). Prions are transmissible particles that are devoid of nucleic acid and seem to be composed exclusively of a modified protein (PrPSc). The normal, cellular PrP (PrPC) is converted into PrPSc through a posttranslational process during which it acquires a high beta-sheet content. In fCJD, GSS, and FFI, mutations in the PrP gene located on the short arm of chromosome 20 are the cause of disease. Considerable evidence argues that the prion diseases are disorders of protein conformation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9669700

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  120 in total

1.  Molecular modelling indicates that the pathological conformations of prion proteins might be beta-helical.

Authors:  D T Downing; N D Lazo
Journal:  Biochem J       Date:  1999-10-15       Impact factor: 3.857

2.  14-3-3 proteins in neurological disorders.

Authors:  Molly Foote; Yi Zhou
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

3.  Characterization of the prion protein in human urine.

Authors:  Ayuna Dagdanova; Serguei Ilchenko; Silvio Notari; Qiwei Yang; Mark E Obrenovich; Kristen Hatcher; Peter McAnulty; Lequn Huang; Wenquan Zou; Qingzhong Kong; Pierluigi Gambetti; Shu G Chen
Journal:  J Biol Chem       Date:  2010-07-29       Impact factor: 5.157

4.  Conformational plasticity of recombinant bovine prion protein.

Authors:  V B Grigoriev; S L Kalnov; A N Pokidyshev; S M Klimenko
Journal:  Dokl Biochem Biophys       Date:  2010 Jan-Feb       Impact factor: 0.788

5.  Mechanistic Insights into Hsp104 Potentiation.

Authors:  Mariana P Torrente; Edward Chuang; Megan M Noll; Meredith E Jackrel; Michelle S Go; James Shorter
Journal:  J Biol Chem       Date:  2016-01-08       Impact factor: 5.157

Review 6.  Techniques to elucidate the conformation of prions.

Authors:  Martin L Daus
Journal:  World J Biol Chem       Date:  2015-08-26

7.  In vitro polymerization of a functional Escherichia coli amyloid protein.

Authors:  Xuan Wang; Daniel R Smith; Jonathan W Jones; Matthew R Chapman
Journal:  J Biol Chem       Date:  2006-12-12       Impact factor: 5.157

8.  Contributions of neuronal prion protein on sleep recovery and stress response following sleep deprivation.

Authors:  Manuel Sánchez-Alavez; Bruno Conti; Gianluca Moroncini; José R Criado
Journal:  Brain Res       Date:  2007-05-22       Impact factor: 3.252

9.  Quality evaluation for the surveillance system of human prion diseases in China based on the data from 2010 to 2016.

Authors:  Qi Shi; Wei Zhou; Cao Chen; Chen Gao; Kang Xiao; Jing Wang; Bao-Yun Zhang; Yuan Wang; Feng Zhang; Xiao-Ping Dong
Journal:  Prion       Date:  2016-11       Impact factor: 3.931

Review 10.  Immunotherapy in prion disease.

Authors:  Yvonne Roettger; Yansheng Du; Michael Bacher; Inga Zerr; Richard Dodel; Jan-Philipp Bach
Journal:  Nat Rev Neurol       Date:  2012-12-18       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.